Development of a recombinant vaccine against human onchocerciasis.

Authors

• David Abraham
• John Graham-Brown
• Darrick Carter
• Sean A Gray
• Jessica A Hess
• Benjamin L Makepeace
• Sara Lustigman

Publication/Presentation Date

11-1-2021

Abstract

INTRODUCTION: Human onchocerciasis caused by the filarial nematode parasite

AREAS COVERED: Models used to study immunity to

EXPERT OPINION: The adjuvanted

Volume

20

Issue

11

First Page

1459

Last Page

1470

ISSN

1744-8395

Published In/Presented At

Abraham, D., Graham-Brown, J., Carter, D., Gray, S. A., Hess, J. A., Makepeace, B. L., & Lustigman, S. (2021). Development of a recombinant vaccine against human onchocerciasis. Expert review of vaccines, 20(11), 1459–1470. https://doi.org/10.1080/14760584.2021.1977125

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

34488533

Department(s)

Administration and Leadership

Document Type

Article